ID 205187091 · FY 2020–2023 · 4 years
რომლის ძირითადი საქმიანობაა საცალო ვაჭრობა სამედიცინო და ორთოპედიული საქონლით სპეციალიზებულ მაღაზიებში, საბითუმო ვაჭრობა ფარმაცევტული საქონლით.
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Ratio | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Margins | ||||
| Gross Margin | 39.7% | 35.5% | 14.2% | 27.4% |
| EBITDA Margin | 28.2% | 21.6% | -4.1% | 1.1% |
| EBITDAR | 1,078 | 712 | -102 | 19 |
| EBITDAR Margin | 28.2% | 21.6% | -4.1% | 1.1% |
| EBIT Margin | 27.9% | 21.2% | -4.6% | -0.0% |
| Net Profit Margin | 28.4% | 21.1% | -5.8% | -0.8% |
| Operating Expense % of Sales | 11.4% | 13.9% | 18.3% | 26.3% |
| Returns | ||||
| Return on Assets (ROA) | 34.9% | 21.2% | -5.2% | -0.5% |
| Return on Equity (ROE) | 41.9% | 21.3% | -5.2% | -0.5% |
| ROIC [EBIT / Invested Capital] | 47.2% | 23.8% | -5.3% | -0.0% |
| Leverage & liquidity | ||||
| Debt-to-Assets | 0.0% | 0.0% | 0.0% | 0.0% |
| Debt-to-Equity | 0.00x | 0.00x | 0.00x | 0.00x |
| Debt-to-EBITDA | 0.00x | 0.00x | N/A | 0.00x |
| Equity-to-Assets | 83.3% | 99.8% | 99.7% | 99.5% |
| Net Debt | -324 | -336 | -644 | -329 |
| Cash & Equivalents | 324 | 336 | 644 | 329 |
| Total Debt | N/A | N/A | N/A | N/A |
| Efficiency & working capital | ||||
| Inventory Turnover | 4.89x | N/A | N/A | N/A |
| Days Inventory Outstanding (DIO) | 74.7 | N/A | N/A | N/A |
| Receivables Turnover | 16.54x | 11.00x | 6.91x | 5.67x |
| Days Sales Outstanding (DSO) | 22.1 | 33.2 | 52.8 | 64.4 |
| Payables Turnover | 374.40x | 617.37x | 491.16x | 110.32x |
| Days Payable Outstanding (DPO) | 1.0 | 0.6 | 0.7 | 3.3 |
| Cash Conversion Cycle | 95.8 days | 32.6 days | 52.1 days | 61.1 days |
| Asset Turnover | 1.23x | 1.01x | 0.89x | 0.66x |
| Cash flow & dividends | ||||
| Operating Cash Flow | 542 | 60 | 663 | 217 |
| Free Cash Flow (OCF − Capex proxy) | 523 | 35 | 657 | 32 |
| Cash Conversion (OCF / EBITDA) | 50.3% | 8.5% | N/A | 1128.8% |
| Dividends Declared | N/A | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in ₾ '000. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Companies sharing this sub-sector, ranked by how close their latest revenue is to this one — not a curated comp set.
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).